Neurocognitive deficits in children with sickle cell disease: a comprehensive profile

Channa T Hijmans1, Karin Fijnvandraat, Martha A Grootenhuis

  • 1Psychosocial Department, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands. c.t.hijmans@amc.nl

Insights

Children with sickle cell disease (SCD) often experience lower IQ scores and visuo-motor deficits. These neurocognitive impairments highlight the need for regular evaluations and interventions in affected children.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Hematology

Background:

  • Sickle cell disease (SCD) is linked to significant cerebral damage and neurocognitive deficits.
  • Understanding specific cognitive impairments in children with SCD is crucial for targeted interventions.

Purpose of the Study:

  • To comprehensively assess neurocognitive functions in children with SCD.
  • To compare cognitive performance in children with SCD against a socioeconomically matched control group.

Main Methods:

  • Assessed 41 children with homozygous SCD and 38 controls using validated neurocognitive measures.
  • Evaluated general intelligence, executive functions (including working memory, attention, planning), and visuo-motor skills.

Main Results:

  • Children with SCD had lower IQ scores, with over one-third scoring below 75.
  • Deficits were observed in visuo-motor functioning, visuo-spatial working memory, sustained attention, and planning.
  • No significant differences were found in response inhibition or verbal working memory.

Conclusions:

  • Children with SCD face increased risks of intellectual, visuo-motor, and executive function impairments.
  • These deficits likely contribute to scholastic difficulties in children with SCD.
  • Regular neurocognitive evaluations and rehabilitation programs are essential for managing SCD-related cognitive issues.
Abstract

Related Concept Videos

Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...